Search
User Avatar Login
The Defender
  • Explore The Defender
  • Categories
    • CHD.TV
  • Explore CHD.TV
  • Archive
    • Resources
  • Explore Our Resources
  • CHD Bookstore
  • CHD Films
  • eBooks
    • Community
  • Explore Advocacy
  • Community
  • Advocacy Help
    • Science
  • Explore the Science Section
  • Science Library
  • Vaccines
  • Electromagnetic Radiation
    • Legal Justice
  • Explore Litigation
  • Learn The Law
    • About Us
  • About Children’s Health Defense
  • More from CHD
    • Vax-Unvax: Let The Science Speak Home › Citations

    Chapter 7

    This is a listing of all citations in this chapter.

    31

    Matthew Wise, et al., “Guillain-Barre Syndrome During the 2009-2010 H1N1 Influenza Vaccination Campaign: Population-Based Surveillance Among 45 Million Americans,” American Journal of Epidemiology 175, no. 11 (2012): 1110–1119, doi:10.1093/aje/kws196.

    32

    Daniel A. Salmon et al., “Association Between Guillain-Barré Syndrome and Influenza A (H1N1) 2009 Monovalent Inactivated Vaccines in the USA: A Meta-Analysis,” Lancet 381, no. 9876 (2013): 1461-1468, doi:10.1016/S0140-6736(12)62189-8.

    33

    Daniel A. Salmon et al., “Association Between Guillain-Barré Syndrome and Influenza A (H1N1) 2009 Monovalent Inactivated Vaccines in the USA: A Meta-Analysis,” Lancet 381, no. 9876 (2013): 1461-1468, doi:10.1016/S0140-6736(12)62189-8.

    34

    Sharon Rikin et al., “Assessment of Temporally-Related Acute Respiratory Illness Following Influenza Vaccination,” Vaccine 36, no. 15 (2018): 1958-1964, doi:10.1016/j.vaccine.2018.02.105.

    35

    Sharon Rikin et al., “Assessment of Temporally-Related Acute Respiratory Illness Following Influenza Vaccination,” Vaccine 36, no. 15 (2018): 1958-1964, doi:10.1016/j.vaccine.2018.02.105.

    36

    Sharon Rikin et al., “Assessment of Temporally-Related Acute Respiratory Illness Following Influenza Vaccination,” Vaccine 36, no. 15 (2018): 1958-1964, doi:10.1016/j.vaccine.2018.02.105.

    37

    Sharon Rikin et al., “Assessment of Temporally-Related Acute Respiratory Illness Following Influenza Vaccination,” Vaccine 36, no. 15 (2018): 1958-1964, doi:10.1016/j.vaccine.2018.02.105.

    38

    Greg G. Wolff, “Influenza Vaccination and Respiratory Virus Interference Among Department of Defense Personnel During the 2017-2018 Influenza Season,” Vaccine 38, no. 2 (2020): 350-354, doi:10.1016/j.vaccine.2019.10.005.

    39

    Greg G. Wolff, “Influenza Vaccination and Respiratory Virus Interference Among Department of Defense Personnel During the 2017-2018 Influenza Season,” Vaccine 38, no. 2 (2020): 350-354, doi:10.1016/j.vaccine.2019.10.005.

    40

    Benjamin J. Cowling et al., “Increased Risk of Noninfluenza Respiratory Virus Infections Associated with Receipt of Inactivated Influenza Vaccine,” Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54, no. 12 (2012): 1778–1783, doi:10.1093/cid/cis307.

    41

    Benjamin J. Cowling et al., “Increased Risk of Noninfluenza Respiratory Virus Infections Associated with Receipt of Inactivated Influenza Vaccine,” Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54, no. 12 (2012): 1778–1783, doi:10.1093/cid/cis307.

    42

    Benjamin J. Cowling et al., “Increased Risk of Noninfluenza Respiratory Virus Infections Associated with Receipt of Inactivated Influenza Vaccine,” Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54, no. 12 (2012): 1778–1783, doi:10.1093/cid/cis307.

    43

    Alexa Dierig et al., “Epidemiology of Respiratory Viral Infections in Children Enrolled in a Study of Influenza Vaccine Effectiveness,” Influenza and Other Respiratory Viruses 8, no. 3 (2014): 293–301, doi:10.1111/irv.12229.

    44

    Alexa Dierig et al., “Epidemiology of Respiratory Viral Infections in Children Enrolled in a Study of Influenza Vaccine Effectiveness,” Influenza and Other Respiratory Viruses 8, no. 3 (2014): 293–301, doi:10.1111/irv.12229.

    45

    Alexa Dierig et al., “Epidemiology of Respiratory Viral Infections in Children Enrolled in a Study of Influenza Vaccine Effectiveness,” Influenza and Other Respiratory Viruses 8, no. 3 (2014): 293–301, doi:10.1111/irv.12229.

    46

    Avni Y. Joshi et al., “Effectiveness of Trivalent Inactivated Influenza Vaccine in Influenza-Related Hospitalization in Children: A Case-Control Study,” Allergy and Asthma Proceedings 33, no. 2 (2012): e23–e27, doi:10.2500/aap.2012.33.3513.

    47

    Avni Y. Joshi et al., “Effectiveness of Trivalent Inactivated Influenza Vaccine in Influenza-Related Hospitalization in Children: A Case-Control Study,” Allergy and Asthma Proceedings 33, no. 2 (2012): e23–e27, doi:10.2500/aap.2012.33.3513.

    48

    Avni Y. Joshi et al., “Effectiveness of Trivalent Inactivated Influenza Vaccine in Influenza-Related Hospitalization in Children: A Case-Control Study,” Allergy and Asthma Proceedings 33, no. 2 (2012): e23–e27, doi:10.2500/aap.2012.33.3513.

    49

    Gaetano A. Lanza et al., “Inflammation-Related Effects of Adjuvant Influenza A Vaccination on Platelet Activation and Cardiac Autonomic Function,” Journal of Internal Medicine, 269 no.1 (2011): 118–125. doi:10.1111/j.1365-2796.2010.02285.x.

    50

    Gaetano A. Lanza et al., “Inflammation-Related Effects of Adjuvant Influenza A Vaccination on Platelet Activation and Cardiac Autonomic Function,” Journal of Internal Medicine, 269 no.1 (2011): 118–125. doi:10.1111/j.1365-2796.2010.02285.x.

    51

    MedAlerts.org., “Search Results From the 6/10/2022 release of VAERS data: Found 17,929 cases where Vaccine targets Influenza (FLU(H1N1) or FLU3 or FLU4 or FLUA3 or FLUA4 or FLUC3 or FLUC4 or FLUN(H1N1) or FLUN3 or FLUN4 or FLUR3 or FLUR4 or FLUX or FLUX(H1N1) or H5N1) and Standard-MedDRA-Query broadly-matches ‘Cardiomyopathy,’” National Vaccine Information Center, Retrieved from:

    52

    Jeff Kwong et al., “Risk of Guillain-Barré Syndrome After Seasonal Influenza Vaccination and Influenza Health-Care Encounters: A Self-Controlled Study,” The Lancet: Infectious Diseases 13, no.9: 769-776, doi:10.1016/S1473-3099(13)70104-X.

    53

    David Juurlink, et al., “Guillain-Barré Syndrome After Influenza Vaccination in Adults: A Population-Based Study,” Journal of the American Medical Association 166, no. 20 (2006): 2217–2221, doi:10.1001/archinte.166.20.2217.

    54

    Tamar Lasky, et al., “The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994Influenza Vaccines,” The New England Journal of Medicine 339, no. 25 (1998): 1797-1802, doi:10.1056/NEJM199812173392501.

    55

    Sharon Rikin et al., “Assessment of Temporally-Related Acute Respiratory Illness Following Influenza Vaccination,” Vaccine 36, no. 15 (2018): 1958-1964, doi:10.1016/j.vaccine.2018.02.105.

    56

    Greg G. Wolff, “Influenza Vaccination and Respiratory Virus Interference Among Department of Defense Personnel During the 2017-2018 Influenza Season,” Vaccine 38, no. 2 (2020): 350-354, doi:10.1016/j.vaccine.2019.10.005.

    57

    Sharon Rikin et al., “Assessment of Temporally-Related Acute Respiratory Illness Following Influenza Vaccination,” Vaccine 36, no. 15 (2018): 1958-1964, doi:10.1016/j.vaccine.2018.02.105.

    58

    Greg G. Wolff, “Influenza Vaccination and Respiratory Virus Interference Among Department of Defense Personnel During the 2017-2018 Influenza Season,” Vaccine 38, no. 2 (2020): 350-354, doi:10.1016/j.vaccine.2019.10.005.

    59

    Greg G. Wolff, “Influenza Vaccination and Respiratory Virus Interference Among Department of Defense Personnel During the 2017-2018 Influenza Season,” Vaccine 38, no. 2 (2020): 350-354, doi:10.1016/j.vaccine.2019.10.005.

    60

    Avni Y. Joshi et al., “Effectiveness of Trivalent Inactivated Influenza Vaccine in Influenza-Related Hospitalization in Children: A Case-Control Study,” Allergy and Asthma Proceedings 33, no. 2 (2012): e23–e27, doi:10.2500/aap.2012.33.3513